Geistlich Pharma Ag
Clinical trials sponsored by Geistlich Pharma Ag, explained in plain language.
-
New patch aims to fix knee cartilage – but study halted early
Disease control TerminatedThis study tested a special collagen membrane (Chondro-Gide®) to help repair damaged knee cartilage in 75 people aged 18-55. The goal was to see if the membrane safely improves cartilage healing, measured by MRI scans and knee function scores. The trial was terminated early, so r…
Phase: NA • Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated May 26, 2026 09:44 UTC
-
New collagen patch aims to repair large knee cartilage defects
Disease control TerminatedThis study tested whether a special collagen cover (Chondro-Gide) placed over large knee cartilage injuries, combined with microfracture surgery, works as well as microfracture alone for smaller injuries. The trial enrolled 82 people aged 18-55 with knee cartilage damage. The mai…
Phase: NA • Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated May 26, 2026 09:31 UTC